Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Tax Provisions: 2009-2018

Historic Tax Provisions for China Pharma Holdings (CPHI) over the last 10 years, with Dec 2018 value amounting to -$66,498.

  • China Pharma Holdings' Tax Provisions fell 317.85% to -$66,498 in Q4 2018 from the same period last year, while for Dec 2018 it was -$178,408, marking a year-over-year decrease of 245.48%. This contributed to the annual value of -$178,408 for FY2018, which is 245.48% down from last year.
  • Per China Pharma Holdings' latest filing, its Tax Provisions stood at -$66,498 for Q4 2018, which was up 58.56% from -$160,485 recorded in Q3 2018.
  • In the past 5 years, China Pharma Holdings' Tax Provisions ranged from a high of $243,131 in Q4 2016 and a low of -$160,485 during Q3 2018.
  • Its 3-year average for Tax Provisions is $20,998, with a median of $25,985 in 2018.
  • Its Tax Provisions has fluctuated over the past 5 years, first soared by 8,718.61% in 2016, then plummeted by 614.41% in 2018.
  • Quarterly analysis of 5 years shows China Pharma Holdings' Tax Provisions stood at -$19,284 in 2014, then soared by 85.37% to -$2,821 in 2015, then soared by 8,718.61% to $243,131 in 2016, then plummeted by 87.45% to $30,525 in 2017, then tumbled by 317.85% to -$66,498 in 2018.
  • Its Tax Provisions was -$66,498 in Q4 2018, compared to -$160,485 in Q3 2018 and $22,590 in Q2 2018.